Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Molecular and Clinical Oncology|February 20, 2018
Novel BRAF mutation in melanoma: A case reportSerena Trubini, Alessandro Ubiali, Carlo Terenzio Paties, et al.Diagnostics (Basel, Switzerland)|May 24, 2024
Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic ReviewElena Orlandi, Mario Giuffrida, Serena Trubini, et al.Anticancer Research|April 25, 2023
Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant TreatmentElena Orlandi, Andrea Romboli, Chiara Citterio, et al.Cancers|August 29, 2024
Exploring the Horizon: Anti-Fibroblast Growth Factor Receptor Therapy in Pancreatic Cancer with Aberrant Fibroblast Growth Factor Receptor Expression-A Scoping ReviewElena Orlandi, Massimo Guasconi, Stefano Vecchia, et al.Oncology Letters|August 20, 2024
Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo‑immunotherapy: A case reportElena Orlandi, Ilaria Toscani, Serena Trubini, et al.Mycoses|September 13, 2025
Inter-Hospital Spread of Fluconazole-Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm ProductionGiorgia Palladini, Valentina Lepera, Serena Trubini, et al.European Journal of Cancer (Oxford, England : 1990)|October 3, 2021
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in ItalyLuigi Cavanna, Chiara Citterio, Claudia Biasini, et al.Clinical Lung Cancer|April 12, 2020
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective StudyRoberta Minari, Giulia Mazzaschi, Paola Bordi, et al.Cancers|April 23, 2022
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring <i>BRAF</i> Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E SubgroupsFabiana Perrone, Giulia Mazzaschi, Roberta Minari, et al.Clinical Lung Cancer|August 24, 2022
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective StudyGiulia Mazzaschi, Fabiana Perrone, Roberta Minari, et al.Pageof 2